BenevolentAI to present at 41st Annual J.P. Morgan Healthcare Conference
BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, US from 9-12 January 2023.

Dec 1, 2022